What is Qualigen Therapeutics, Inc.'s stock symbol?

Our stock is traded on the Nasdaq under the symbol QLGN.

When was Qualigen Therapeutics, Inc. incorporated?

Qualigen, Inc. was originally incorporated in Minnesota as a privately held corporation in 1996. Qualigen Therapeutics, Inc. (formerly Ritter Pharmaceuticals, Inc.) was formed as a Nevada limited liability company on March 29, 2004 under the name Ritter Natural Sciences, LLC. In September 2008, the company was converted into a Delaware corporation under the name Ritter Pharmaceuticals, Inc. In May 2020, Ritter Pharmaceuticals, Inc. entered into a reverse merger transaction with Qualigen, Inc. pursuant to which Qualigen, Inc. became a wholly-owned subsidiary of Ritter Pharmaceuticals, Inc. Following the reverse merger transaction, Ritter Pharmaceuticals, Inc. changed its name to Qualigen Therapeutics, Inc

When did Qualigen Therapeutics, Inc. become a public company?

June 29, 2015 as Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR). Renamed Qualigen Therapeutics, Inc. on May 22, 2020 (Nasdaq: QLGN).

Where is Qualigen Therapeutics, Inc. located?

2042 Corte del Nogal
Suite B
Carlsbad, CA 92011

When is Qualigen Therapeutics, Inc.'s fiscal year end?

December 31st

Who is Qualigen Therapeutics, Inc.'s transfer agent?

EQ Shareowner Services
PO Box 64874
St Paul MN 55164
T: 800-468-9716

Who is Qualigen Therapeutics, Inc.'s independent auditor?

Baker Tilly US, LLP

Who is Qualigen Therapeutics, Inc.'s outside legal counsel?

Stradling Yocca Carlson & Rauth, P.C.